Claudio Guarneri
机构：University of Messina, Azienda Ospedaliera Universitaria Policlinico "G. Martino" · ORCID：0000-0003-3918-8779
发表论文 448 篇 · 总被引 4325 次 · h-index 35
代表论文
- Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis) (2024 · Journal of Dermatological Treatment · 被引 21)
- Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study – IL PSO (Italian Landscape Psoriasis) (2024 · Journal of Dermatological Treatment · 被引 15)
- Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network (2024 · Expert Opinion on Biological Therapy · 被引 15)
- Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis) (2025 · Dermatology and Therapy · 被引 12)
- Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis) (2024 · Dermatology and Therapy · 被引 12)
- Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study (2024 · Journal of the European Academy of Dermatology and Venereology · 被引 10)